Literature DB >> 26291735

Breastfeeding as an Exposure Pathway for Perfluorinated Alkylates.

Ulla B Mogensen1, Philippe Grandjean2,3, Flemming Nielsen2, Pal Weihe4, Esben Budtz-Jørgensen1.   

Abstract

Perfluorinated alkylate substances (PFASs) are widely used and have resulted in human exposures worldwide. PFASs occur in breast milk, and the duration of breastfeeding is associated with serum-PFAS concentrations in children. To determine the time-dependent impact of this exposure pathway, we examined the serum concentrations of five major PFASs in a Faroese birth cohort at birth, and at ages 11, 18, and 60 months. Information about the children's breastfeeding history was obtained from the mothers. The trajectory of serum-PFAS concentrations during months with and without breastfeeding was examined by linear mixed models that accounted for the correlations of the PFAS measurements for each child. The models were adjusted for confounders such as body size. The duration of exclusive breastfeeding was associated with increases of most PFAS concentrations by up to 30% per month, with lower increases during partial breast-feeding. In contrast to this main pattern, perfluorohexanesulfonate was not affected by breast-feeding. After cessation of breastfeeding, all serum concentrations decreased. This finding supports the evidence of breastfeeding being an important exposure pathway to some PFASs in infants.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26291735      PMCID: PMC6190571          DOI: 10.1021/acs.est.5b02237

Source DB:  PubMed          Journal:  Environ Sci Technol        ISSN: 0013-936X            Impact factor:   9.028


  25 in total

Review 1.  Breastfeeding and the weanling's dilemma.

Authors:  Philippe Grandjean; Allan Astrup Jensen
Journal:  Am J Public Health       Date:  2004-07       Impact factor: 9.308

2.  Serum vaccine antibody concentrations in children exposed to perfluorinated compounds.

Authors:  Philippe Grandjean; Elisabeth Wreford Andersen; Esben Budtz-Jørgensen; Flemming Nielsen; Kåre Mølbak; Pal Weihe; Carsten Heilmann
Journal:  JAMA       Date:  2012-01-25       Impact factor: 56.272

Review 3.  Health risks of dietary exposure to perfluorinated compounds.

Authors:  José L Domingo
Journal:  Environ Int       Date:  2011-08-23       Impact factor: 9.621

Review 4.  Polyfluorinated compounds: past, present, and future.

Authors:  Andrew B Lindstrom; Mark J Strynar; E Laurence Libelo
Journal:  Environ Sci Technol       Date:  2011-09-09       Impact factor: 9.028

5.  Brominated flame retardants and perfluorinated compounds in indoor dust from homes and offices in Flanders, Belgium.

Authors:  Wendy D'Hollander; Laurence Roosens; Adrian Covaci; Christa Cornelis; Hans Reynders; Karen Van Campenhout; Pim de Voogt; Lieven Bervoets
Journal:  Chemosphere       Date:  2010-08-14       Impact factor: 7.086

6.  Indoor sources of poly- and perfluorinated compounds (PFCS) in Vancouver, Canada: implications for human exposure.

Authors:  Mahiba Shoeib; Tom Harner; Glenys M Webster; Sum Chi Lee
Journal:  Environ Sci Technol       Date:  2011-02-18       Impact factor: 9.028

7.  Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia.

Authors:  Scott M Bartell; Antonia M Calafat; Christopher Lyu; Kayoko Kato; P Barry Ryan; Kyle Steenland
Journal:  Environ Health Perspect       Date:  2010-02       Impact factor: 9.031

8.  Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood.

Authors:  Berit Granum; Line S Haug; Ellen Namork; Solvor B Stølevik; Cathrine Thomsen; Ingeborg S Aaberge; Henk van Loveren; Martinus Løvik; Unni C Nygaard
Journal:  J Immunotoxicol       Date:  2013-01-25       Impact factor: 3.000

9.  Relationships of perfluorooctanoate and perfluorooctane sulfonate serum concentrations between mother-child pairs in a population with perfluorooctanoate exposure from drinking water.

Authors:  Debapriya Mondal; Maria-Jose Lopez-Espinosa; Ben Armstrong; Cheryl R Stein; Tony Fletcher
Journal:  Environ Health Perspect       Date:  2012-01-23       Impact factor: 9.031

10.  Breastfeeding: a potential excretion route for mothers and implications for infant exposure to perfluoroalkyl acids.

Authors:  Debapriya Mondal; Rosana Hernandez Weldon; Ben G Armstrong; Lorna J Gibson; Maria-Jose Lopez-Espinosa; Hyeong-Moo Shin; Tony Fletcher
Journal:  Environ Health Perspect       Date:  2013-11-26       Impact factor: 9.031

View more
  48 in total

1.  Thyroid receptor antagonism as a contributory mechanism for adipogenesis induced by environmental mixtures in 3T3-L1 cells.

Authors:  Christopher D Kassotis; Erin M Kollitz; Kate Hoffman; Julie Ann Sosa; Heather M Stapleton
Journal:  Sci Total Environ       Date:  2019-02-18       Impact factor: 7.963

2.  Modeled prenatal exposure to per- and polyfluoroalkyl substances in association with child autism spectrum disorder: A case-control study.

Authors:  Hyeong-Moo Shin; Deborah H Bennett; Antonia M Calafat; Daniel Tancredi; Irva Hertz-Picciotto
Journal:  Environ Res       Date:  2020-04-14       Impact factor: 6.498

3.  Breastfeeding as a Predictor of Serum Concentrations of Per- and Polyfluorinated Alkyl Substances in Reproductive-Aged Women and Young Children: A Rapid Systematic Review.

Authors:  Brianna N VanNoy; Juleen Lam; Ami R Zota
Journal:  Curr Environ Health Rep       Date:  2018-06

4.  Variability and predictors of serum perfluoroalkyl substance concentrations during pregnancy and early childhood.

Authors:  Samantha L Kingsley; Melissa N Eliot; Karl T Kelsey; Antonia M Calafat; Shelley Ehrlich; Bruce P Lanphear; Aimin Chen; Joseph M Braun
Journal:  Environ Res       Date:  2018-05-07       Impact factor: 6.498

5.  Prenatal and childhood exposure to per- and polyfluoroalkyl substances (PFASs) and child cognition.

Authors:  Maria H Harris; Emily Oken; Sheryl L Rifas-Shiman; Antonia M Calafat; Xiaoyun Ye; David C Bellinger; Thomas F Webster; Roberta F White; Sharon K Sagiv
Journal:  Environ Int       Date:  2018-04-26       Impact factor: 9.621

6.  Temporal trends and determinants of serum concentrations of per- and polyfluoroalkyl substances among Northern California mothers with a young child, 2009-2016.

Authors:  Kyunghoon Kim; Deborah H Bennett; Antonia M Calafat; Irva Hertz-Picciotto; Hyeong-Moo Shin
Journal:  Environ Res       Date:  2020-04-09       Impact factor: 6.498

7.  Demographic, Reproductive, and Dietary Determinants of Perfluorooctane Sulfonic (PFOS) and Perfluorooctanoic Acid (PFOA) Concentrations in Human Colostrum.

Authors:  Todd A Jusko; Marina Oktapodas; L'ubica Palkovičová Murinová; Katarina Babinská; Jana Babjaková; Marc-André Verner; Jamie C DeWitt; Kelly Thevenet-Morrison; Kamil Čonka; Beata Drobná; Jana Chovancová; Sally W Thurston; B Paige Lawrence; Ann M Dozier; Kirsi M Järvinen; Henrieta Patayová; Tomáš Trnovec; Juliette Legler; Irva Hertz-Picciotto; Marja H Lamoree
Journal:  Environ Sci Technol       Date:  2016-06-14       Impact factor: 9.028

8.  Estimated exposures to perfluorinated compounds in infancy predict attenuated vaccine antibody concentrations at age 5-years.

Authors:  Philippe Grandjean; Carsten Heilmann; Pal Weihe; Flemming Nielsen; Ulla B Mogensen; Amalie Timmermann; Esben Budtz-Jørgensen
Journal:  J Immunotoxicol       Date:  2017-12       Impact factor: 3.000

Review 9.  Recent developments in polyfluoroalkyl compounds research: a focus on human/environmental health impact, suggested substitutes and removal strategies.

Authors:  John Baptist Nzukizi Mudumbi; Seteno Karabo Obed Ntwampe; Tandi Matsha; Lukhanyo Mekuto; Elie Fereche Itoba-Tombo
Journal:  Environ Monit Assess       Date:  2017-07-18       Impact factor: 2.513

10.  Behavioral difficulties in 7-year old children in relation to developmental exposure to perfluorinated alkyl substances.

Authors:  Youssef Oulhote; Ulrike Steuerwald; Frodi Debes; Pal Weihe; Philippe Grandjean
Journal:  Environ Int       Date:  2016-09-29       Impact factor: 9.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.